1.Evaluation of Treatment Response Using Diffusion-Weighted MRI in Metastatic Spines.
Yeungnam University Journal of Medicine 2001;18(1):30-38
BACKGROUND: The purpose of this study was to evaluated the usefulness of diffusion-weighted magnatic resonance imaging for monitoring the response to radiation therapy in metastatic bone marrow of the spines. MATERIALS AND METHOD: Twenty-one patients with metastatic bone marrow of the spine were examined with MRI. Diffusion-weighted and spin-echo MRI were performed in 10 patients before and after radiation therapy with or without systematic chemotherapy, and performed in 11 patiemts after radiation therapy alone. Follow up spin-echo and diffusion-weighted MRI were obtained at 1 to 6 months after radiation therapy according to patients' condition. The diffusion-weighted imaging sequence was based on reversed fast imaging with steady-state precession(PSIF). Signal intensity changes of the metastatic bone marrows before and after radiation therapy on conventional spin-echo sequence MRI and diffusion-weighted MRI were evaluated. Bone marrow contrast ratios and signal-to-noise ratio before and after radiation therapy of diffusion-weighted MRI were analyzed. RESULTS: All metastatic bone marrow of the spinal bodies were hyperintense to normal bone marrow of the spinal bodies on pretreatment diffusion-weighted MRI and positive bone marrow contrast ratio(p<0.001). and hypointense to normal spinal bodies on posttreatment diffusion-weighted MRI and negative bone marrow contrast ratio(p<0.001). The signal to noise ratio after treatment decreased comparing with those of pretreatment. Decreased signal intensity of the metastatic bone marrows on diffusion-weighted MRI began to be observed at average more than one month after the initiation of the radiation therapy. CONCLUSION: tThese results suggest that diffusion-weighted MRI would be an excellent method for monitoring the response to therapy of metastatic bone marrow of the spinal bodies. However, must be investigated in a larger series of patients with longer follow up period.
Bone Marrow
;
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Magnetic Resonance Imaging*
;
Signal-To-Noise Ratio
;
Spine*
2.Uterine Arterial Embolization for the Treatment of Leiomyomas Accompanying with Adenomyosis.
Jin Beum JANG ; Sang Wook BAI ; Jae Hak LIM ; Do Yeon LEE ; Jung Yeon KIM ; Kyung Ah JEONG ; Sei Kwang KIM ; Ki Hyun PARK
Korean Journal of Fertility and Sterility 2001;28(3):215-224
OBJECTIVE: The purpose of this study was to make a guideline of uterine artery embolization for the treatment of uterine leiomyomas accompanying with adenomyosis in Korea. MATERIALS AND METHODS: We performed the retrospective study for 37 women who had uterine leiomyomas accompanying with adenomyosis. Bilateral uterine artery embolization was performed in 37 patients (age range 25-65) during 17 months with pain, hypermenorrhea, urinary frequency etc due to leiomyomas. Ultrasound imaging was performed before the procedure and at mean 6.9 months after the procedure. RESULTS: All procedures were technically successful. Mean clinical follow-up was 12.8 months. Minor complication occurred in 82% patients after the procedure. After imaging follow-up (mean, 6.9 months postprocedure), median uterine volume decreased 34.4%, and dominant myoma volume decreased 86%. There was no statistical difference in uterine volume reduction and dominant myoma size reduction whether occluding agents was polyvinyl alcohol, polyvinyl alcohol plus gelfoam, and gelfoam, and whether ultrasound measured Resistance Index value before the procedure was low or high. CONCLUSION: Primary candidates for uterine artery embolization include those with symptomatic uterine leiomyomas who no longer desire fertility but wish to avoid surgery or are poor surgical risks. To our study, uterine volume reduction and dominant myoma size reduction in patients who had adenomyosis were similar to previous other studies in patients who had not adenomyosis. Therefore adenomyosis should not be considered as a contraindication for uterine artery embolization. Because there is little data about subsequent reproductive potential after this procedure, it should not be routinely advocated for infertile women. Further investigation is warranted for occluding agents and Resistance Index.
Adenomyosis*
;
Female
;
Fertility
;
Follow-Up Studies
;
Gelatin Sponge, Absorbable
;
Humans
;
Korea
;
Leiomyoma*
;
Menorrhagia
;
Myoma
;
Polyvinyl Alcohol
;
Retrospective Studies
;
Ultrasonography
;
Uterine Artery Embolization
3.Three Korean patients with Cantú syndrome caused by mutations in ABCC9 and their clinical manifestations.
Jin Hee JANG ; Jung Min KO ; Sei Won YANG ; Jong Hee CHAE ; Eun Jung BAE
Journal of Genetic Medicine 2016;13(2):99-104
Cantú syndrome (CS, OMIM 239850) is a very rare autosomal dominantly inherited genetic disease characterized by congenital hypertrichosis, neonatal macrosomia, a distinct facial features such as macrocephaly, and cardiac defects. Since the first description by Cantú et al. in 1982, about 50 cases have been reported to date. Recently, two causative genes for CS has been found by using exome sequencing analyses: ABCC9 and KCNJ8 . Most cases of clinically diagnosed CS have resulted from de novo mutations in ABCC9. In this study, we report three independent Korean children with CS resulting from de novo ABCC9 mutations. Our patients had common clinical findings such as congenital hypertrichosis, distinctive facial features. One of them showed severe pulmonary hypertension and hypertrophic cardiomyopathy, which require medical treatment. And, two patients had a history of patent ductus arteriosus. Although two of our patients had shown early motor developmental delay, it was gradually improved during follow-up periods. Although CS is quite rare, there are the concerns about development of various cardiac problems in the lifetime. Therefore, an accurate diagnosis followed by appropriate management and genetic counseling should be provided to CS patients.
Cardiomyopathy, Hypertrophic
;
Child
;
Databases, Genetic
;
Diagnosis
;
Ductus Arteriosus, Patent
;
Exome
;
Follow-Up Studies
;
Genetic Counseling
;
Humans
;
Hypertension, Pulmonary
;
Hypertrichosis
;
Megalencephaly
4.Leisure Time Physical Activity to Reduce Metabolic Syndrome Risk: A 10-Year Community-Based Prospective Study in Korea
Hoon JO ; Jang Young KIM ; Min Ye JUNG ; Yeon Soon AHN ; Sei Jin CHANG ; Sang Baek KOH
Yonsei Medical Journal 2020;61(3):218-228
PURPOSE: Metabolic syndrome (MetS) is a major public health problem related to increased risks of cardiovascular disease and type 2 diabetes. We investigated whether recommended levels of leisure time physical activity (LTPA) decrease the risk of MetS in a community-based prospective cohort study (Ansung and Ansan cohort).MATERIALS AND METHODS: A total of 3910 adults (1890 men, 2020 women) without MetS examined in 2001–2002 (baseline) were included in this study and followed up from 2013 to 2014. We measured LTPA energy expenditure using the standard metabolic equivalent value [metabolic equivalent of task (MET)-h/wk]. Individuals were categorized into five groups (physically inactive, 0.1 to <7.5, 7.5 to <15.0, 15.0 to <22.5, 22.5 to <40.0, and ≥40.0 MET-h/wk).RESULTS: The mean follow-up period was 11.8 years. Among the cohort, 482 men (25.5%) and 541 women (26.8%) were diagnosed with newly developed MetS. Multivariate logistic analysis revealed a 4.4% lower MetS risk among those performing two to three times the recommended minimum of 7.5 MET-h/wk [multivariate relative risk (RR), 0.956; 95% confidence interval (CI), 0.654–1.398] and a 21.9% lower risk among those performing three to four times the physical activity minimum (multivariate RR, 0.781; 95% CI, 0.574–1.063). This association was only significant in females performing three to four times the minimum (crude RR, 0.655; 95% CI, 0.432–0.994).CONCLUSION: We noted that physical activity at more than 2 times the recommended minimum prevents MetS. Healthcare professionals should encourage inactive adults to be physically active during their leisure time to take advantage of its health benefits.
Adult
;
Cardiovascular Diseases
;
Cohort Studies
;
Delivery of Health Care
;
Energy Metabolism
;
Female
;
Follow-Up Studies
;
Gyeonggi-do
;
Humans
;
Insurance Benefits
;
Korea
;
Leisure Activities
;
Male
;
Metabolic Equivalent
;
Motor Activity
;
Prospective Studies
;
Public Health
5.AM1638, a GPR40-Full Agonist, Inhibited Palmitate- Induced ROS Production and Endoplasmic Reticulum Stress, Enhancing HUVEC Viability in an NRF2-Dependent Manner
Hwan-Jin HWANG ; Joo Won KIM ; SukHwan YUN ; Min Jeong PARK ; Eyun SONG ; Sooyeon JANG ; Ahreum JANG ; Kyung Mook CHOI ; Sei Hyun BAIK ; Hye Jin YOO
Endocrinology and Metabolism 2023;38(6):760-769
Background:
G protein-coupled receptor 40 (GPR40) is a key molecule in diabetes and fatty liver, but its role in endothelial dysfunction remains unclear. Our objective in this study was to determine whether GPR40 agonists protect endothelial cells against palmitatemediated oxidative stress.
Methods:
Human umbilical vein endothelial cells (HUVECs) were used to investigate effects of various GPR40 agonists on vascular endothelium.
Results:
In HUVECs, AM1638, a GPR40-full agonist, enhanced nuclear factor erythroid 2–related factor 2 (NRF2) translocation to the nucleus and heme oxygenase-1 (HO-1) expression, which blocked palmitate-induced superoxide production. Those antioxidant effects were not detected after treatment with LY2922470 or TAK875, GPR40-partial agonists, suggesting that GPR40 regulates reactive oxygen species (ROS) removal in a ligand-dependent manner. We also found that palmitate-induced CCAAT/enhancer‐binding protein homologous protein expression; X-box binding protein-1 splicing, nuclear condensation, and fragmentation; and caspase-3 cleavage were all blocked in an NRF2-dependent manner after AM1638 treatment. Both LY2922470 and TAK875 also improved cell viability independent of the NRF2/ROS pathway by reducing palmitate-mediated endoplasmic reticulum stress and nuclear damage. GPR40 agonists thus have beneficial effects against palmitate in HUVECs. In particular, AM1638 reduced palmitate-induced superoxide production and cytotoxicity in an NRF2/HO-1 dependent manner.
Conclusion
GPR40 could be developed as a good therapeutic target to prevent or treat cardiovascular diseases such as atherosclerosis.
6.The experience of transumbilical endoscopic appendectomies.
Chung Heon LEE ; Won Joong JEON ; Sei Jin YOUN ; Hyo Young YUN ; Lee Chan JANG ; Jae Woon CHOI ; Young Jin SONG ; Dong Hee RYU
Annals of Surgical Treatment and Research 2014;86(5):278-282
Minimally invasive surgery is being widely accepted in various fields of surgery. Although several appendectomy techniques have been reported but, there is no standardization. We report here the experiences of transumbilical endoscopic appendectomy in humans. Between July 2008 and September 2010, ten patients with appendicitis successfully underwent transumbilical endoscopic appendectomies. There were 7 cases of suppurative, 2 cases of gangrenous and 1 case of perforated in operative findings. The ages of the patients were 13-56 years (mean age, 32.7 +/- 15.4 years). Under general anesthesia, a 15-mm port was inserted through the umbilicus and then a two-channel endoscope was inserted in the peritoneal cavity. After appendix identification, counter-traction of the appendix with a direct abdominal wall puncture using a straight round needle prolene was performed to achieve good visualization of the operative field. Tissue dissection was performed using an endoscopic needle knife. Tissue grasping and resected appendix retrieval were done with endoscopic forceps. The average operation time was 79.5 +/- 23.6 minutes (range, 45 to 110 minutes). No procedures were converted to laparoscopic or open appendectomy. Hospital stay was 4-6 days. All patients completely recovered without complications. As it is highly maneuverable, we believe transumbilical endoscopic appendectomy can be a feasible method. And, as surgeons want to proceed from laparoscopic surgery to natural orifice transluminal endoscopic surgery, this procedure could be a triable method.
Abdominal Wall
;
Anesthesia, General
;
Appendectomy*
;
Appendicitis
;
Appendix
;
Endoscopes
;
Endoscopy
;
Hand Strength
;
Humans
;
Laparoscopy
;
Length of Stay
;
Natural Orifice Endoscopic Surgery
;
Needles
;
Peritoneal Cavity
;
Polypropylenes
;
Punctures
;
Surgical Instruments
;
Surgical Procedures, Minimally Invasive
;
Umbilicus
7.Cervical Myelopathy Resulting From Non-Rheumatoid Atlantoaxial Subluxation.
Jin Ok KIM ; Hyo Jeong KIM ; Dong Joo YUN ; Youngchai KO ; Sang Hyun JANG ; Soo Jin YOON ; Gun Sei OH ; Soo Joo LEE
Journal of the Korean Neurological Association 2012;30(3):196-199
Degenerative pannus arising from the atlanto-axial articulation is a rare entity, which is associated with chronic atlanto-axial instability in degenerative arthropathies. Due to cervical instability and the mass effect on the spinal cord, it can produce severe neck pain and compressive myelopathy. We report a case of cervical myelopathy resulting from non-rheumatoid atlanto-axial subluxation. The posterior stabilization provided excellent neurological improvement and pannus regression. Early recognition of this condition is important as the clinical condition will deteriorate without surgical interventions.
Neck Pain
;
Osteoarthritis
;
Spinal Cord
;
Spinal Cord Compression
;
Spinal Cord Diseases
8.The Early Changing Pattern of the B-Type Natriuretic Peptide Concentration and its Significance as a Prognostic Marker after Acute Myocardial Infarction.
Hyunmin CHOE ; Byung Su YOO ; Ho Yeol RYU ; Sang Baek KOH ; Sei Jin CHANG ; Sung Oh HWANG ; Jang Young KIM ; Seung Whan LEE ; Junghan YOON ; Kyung Hoon CHOE
Korean Circulation Journal 2006;36(7):526-534
BACKGROUND AND OBJECTIVES: The BNP concentration varies considerably after the onset of AMI, and this makes it difficult to determine the right time to measure the BNP as a valid prognostic marker. The aim of this study was to examine the early changing patterns of BNP and to decide on the suitable time for measuring the BNP as a prognostic marker after the onset of AMI. SUBJECTS AND METHODS: From Feb 2002 to May 2005, we analyzed the changing patterns of BNP in 321 AMI patients. BNP (Triage(R)) was measured at the acute phase (< or = 24 hr), the early phase (2 to 6 day), the late phase (1 to 4 week) & the long-term phase (>4 week) after the onset of AMI. The end points were major adverse cardiac events (MACE) and cardiovascular death (CVD). RESULTS: The mean BNP was 306.2+/-802.8 at the acute phase (mean: 9.5 hours), 251.9+/-592.8 at the early phase (mean: 5.1 days), 103.1+/-172.9 at the late phase (mean: 26.8 days) and 179.7+/-353.3 pg/mL at the long-term phase (mean: 45.9 days). There were no significant differences of the demographic factors between the MACE and Non-MACE group. Multivariative analysis showed that early phase BNP (p=0.007) and male gender (p=0.009) were significant risk factors for MACE. The early phase BNP (p=0.037) and age (p=0.022) were the significant risk factors of CVD. On the ROC curve, the early phase BNP for predicting the CVD risk was 186 pg/mL (AUC=0.87, p<0.001). The Kaplan-Meier survival curve showed that the survival rate was higher for the patients with an early phase BNP<186 pg/mL than it was for those patients with a BNP> or = 186 pg/mL (p=0.000). CONCLUSION: The early levels or changing patterns of the BNP concentrations following AMI showed different patterns of change depending on several prognostic factors. The early phase (2 to 6 day) BNP concentration after the onset of AMI could be used as a significant prognostic marker.
Demography
;
Humans
;
Male
;
Myocardial Infarction*
;
Natriuretic Peptide, Brain*
;
Prognosis
;
Risk Factors
;
ROC Curve
;
Survival Rate
9.Chronic Inflammatory Demyelinating Polyneuropathy Combined With Limited Cutaneous Systemic Sclerosis.
Eun Kyung LEE ; Dong Joo YUN ; Youngchai KO ; Sang Hyun JANG ; Soo Jin YOON ; Gun Sei OH ; Soo Joo LEE ; Sung Hye PARK
Journal of the Korean Neurological Association 2014;32(1):26-29
Chronic inflammatory demyelinating polyneuropathy (CIDP) has been rarely reported in systemic sclerosis (SSc). We describe the clinical, electrophysiological, and pathologic findings in a 73-year-old female with established limited cutaneous SSc who later developed CIDP. The patient had progressive limb weakness, sensory loss, and slow nerve conduction velocities. Sural nerve biopsy showed evidence of demyelination and remyelination. This case demonstrates that chronic demyelinating polyneuropathy can be an unusual manifestation of SSc, presumably resulting from an immune-mediated process.
Aged
;
Autoimmunity
;
Biopsy
;
Demyelinating Diseases
;
Extremities
;
Female
;
Humans
;
Neural Conduction
;
Polyneuropathies*
;
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
;
Scleroderma, Systemic*
;
Sural Nerve
10.A Case of Chronic Myeloid Leukemia with Multiple Chloromas Treated Successfully with Dasatinib.
Won Young JANG ; Sei Myong CHOI ; Myeong Soon PARK ; Byung Chan AHN ; Mi Hwa HEO ; Jin Young KIM ; Ki Young KWON ; Young Rok DO
Keimyung Medical Journal 2015;34(2):120-126
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of the primitive hematopoietic stem cells. CML is characterized by the overproduction of myeloid cells, which results in marked splenomegaly and leukocytosis. CML presented by multiple chloromas is extremely rare. Multiple chloromas in the skin and brain are quite rare as the initial presentation of CML. These rare manifestation should alert clinicians to include CML in the differential diagnosis of patients presenting with multiple non-pruritic skin nodules or neurologic symptoms. Dasatinib has promising therapeutic potential for managing intracranial leukemic disease. Here, we report the case of a patient who visited the hospital with multiple chloroma which is unusual presentation of CML, and treated with dasatinib successfully.
Brain
;
Diagnosis, Differential
;
Hematopoietic Stem Cells
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
;
Leukocytosis
;
Myeloid Cells
;
Myeloproliferative Disorders
;
Neurologic Manifestations
;
Sarcoma, Myeloid*
;
Skin
;
Splenomegaly
;
Dasatinib